Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in Cushing’s disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: Late-night salivary cortisol (LNSC) is well-validated in the diagnosis of Cushing's disease (CD). The accuracy of LNSC during follow-up of patients undergoing transsphenoidal surgery (TSS) has not been fully characterized. OBJECTIVES: We examined the accuracy of LNSC in establishing remission and identifying recurrence in postoperative patients with CD. DESIGN: This is a retrospective study. PATIENTS: Records of patients with CD who underwent TSS by a single neurosurgeon in our tertiary center (2005-2014) were analyzed (N = 224). Patients were selected for further investigation (n = 165) if there was at least one available LNSC test obtained after TSS (either within 3 months or during long-term follow-up). Extracted data included demographic and clinical characteristics, magnetic resonance imaging and laboratory data (morning serum cortisol, 24-hour urine free cortisol [UFC], LNSC) . MAIN OUTCOMES AND MEASURES: Remission was defined as nadir morning serum cortisol less than 5 mcg/dl and nadir 24-hour UFC less than 23 mcg. Recurrence was considered definite if confirmed surgically or prompted radiotherapy. RESULTS: Surgical remission occurred in 89% of 89 patients with available LNSC data. LNSC, obtained within 3 months of TSS, established remission with 94% sensitivity and 80% specificity at a cutpoint of 1.9 nmol/l (area under the curve [AUC] = 0.90). At a median follow-up of 53.5 months, LNSC established recurrence (75% sensitivity and 95% specificity) at a cutpoint of 7.4 nmol/l (AUC = 0.87), and 24-hour UFC established recurrence (68% sensitivity and 100% specificity) at a cutpoint of 1.6-fold above normal (AUC = 0.82). CONCLUSIONS: LNSC may accurately establish remission after TSS and identify recurrence more accurately than 24-hour UFC during long-term follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of the nadir of cortisol secretion late at night is the earliest detectable biochemical abnormality in patients with recurrent CD often preceding elevations of urine cortisol or an abnormal low-dose DST [78, 80, 82, 83]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [78]
In the citing paper
“as many as 30% to 50% of CD patients will have either persistent or recurrent hypercortisolism after initial pituitary surgery [78-81]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [78]
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationRoelfsema, F., Biermasz, N. R., & Pereira, A. M. (2012) · Pituitary · doi:10.1007/s11102-011-0347-7 · Cited by 346
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Self-citationYap, L. B., Turner, H. E., Adams, C. B. T., & Wass, J. A. H. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01444.x · Cited by 203
Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications
Inder, W. J., Dimeski, G., & Russell, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04508.x · Cited by 195
Late-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194
Esposito, F., Dusick, J. R., Cohan, P., Moftakhar, P., McArthur, D., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1204 · Cited by 192
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee, G. H., Mathias, D. B., James, R. A., & Kendall‐Taylor, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01261.x · Cited by 182
Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.
Liu, H., Bravata, D. M., Cabaccan, J., Raff, H., & Ryzen, E. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02395.x · Cited by 178
Pereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173
Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease
Valassi, E., Biller, B. M. K., Swearingen, B., Pecori Giraldi, F., Losa, M., Mortini, P., Hayden, D., Cavagnini, F., & Klibanski, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1672 · Cited by 160
Self-citationHigh variability in baseline urinary free cortisol values in patients with Cushing's disease
Petersenn, S., Newell‐Price, J., Findling, J. W., Gu, F., Maldonado, M., Sen, K., Salgado, L. R., Colao, A., Biller, B. M. K., & Pasireotide B2305 Study Group (2014) · Clinical Endocrinology · doi:10.1111/cen.12259 · Cited by 150
Self-citationNunes, M.-L., Vattaut, S., Corcuff, J.-B., Rault, A., Loiseau, H., Gatta, B., Valli, N., Letenneur, L., & Tabarin, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1542 · Cited by 129
New enzyme immunoassay for salivary cortisol
Raff, H., Homar, P. J., & Skoner, D. P. (2003) · Clinical Chemistry · doi:10.1373/49.1.203 · Cited by 116
Estrada, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5695 · Cited by 111
High fluid intake increases urine free cortisol excretion in normal subjects.
Mericq, M. V., & Cutler, G. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4555 · Cited by 111
Carrasco, C. A., Coste, J., Guignat, L., Groussin, L., Dugué, M. A., Gaillard, S., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1171 · Cited by 83
Ceccato, F., Barbot, M., Zilio, M., Ferasin, S., Occhi, G., Daniele, A., Mazzocut, S., Iacobone, M., Betterle, C., Mantero, F., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0159 · Cited by 75
Predicting relapse after transsphenoidal surgery for Cushing's disease
Toms, G. C., McCarthy, M. I., Niven, M. J., Orteu, C. H., King, T. T., & Monson, J. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432771 · Cited by 71
Pituitary Surgery and Postoperative Management in Cushing's Disease
Utz, A. L., Swearingen, B., & Biller, B. M. K. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.007 · Cited by 65
Self-citationBou Khalil, R., Baudry, C., Guignat, L., Carrasco, C., Guibourdenche, J., Gaillard, S., Bertagna, X., & Bertherat, J. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0424 · Cited by 58
Is urinary free cortisol of value in the diagnosis of Cushingʼs syndrome?
Alexandraki, K. I., & Grossman, A. B. (2011) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e3283487193 · Cited by 57
Tritos, N. A., & Biller, B. M. K. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00015-0 · Cited by 51
Self-citationCastinetti, F., Martinie, M., Morange, I., Dufour, H., Sturm, N., Passagia, J.-G., Conte-Devolx, B., Chabre, O., & Brue, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2234 · Cited by 51
Effects of lifestyle factors on concentrations of salivary cortisol in healthy individuals
Garde, A. H., Persson, R., Hansen, Å. M., Österberg, K., Ørbæk, P., Eek, F., & Karlson, B. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802483708 · Cited by 49
Zerikly, R. K., Amiri, L., Faiman, C., Gupta, M., Singh, R. J., Nutter, B., Kennedy, L., Hatipoglu, B., Weil, R. J., & Hamrahian, A. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2458 · Cited by 48
Danet‐Lamasou, M., Asselineau, J., Perez, P., Vivot, A., Nunes, M., Loiseau, H., San‐Galli, F., Cherifi‐Gatta, B., Corcuff, J., & Tabarin, A. (2015) · Clinical Endocrinology · doi:10.1111/cen.12534 · Cited by 39
Carrasco, C. A., García, M., Goycoolea, M., Cerda, J., Bertherat, J., Padilla, O., Meza, D., Wohllk, N., & Quiroga, T. (2012) · Endocrine · doi:10.1007/s12020-012-9597-z · Cited by 34
Ayala, A. R., & Manzano, A. J. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1508-0 · Cited by 32
Doi, S. A. R., Clark, J. M., & Russell, A. W. (2012) · Endocrine · doi:10.1007/s12020-012-9855-0 · Cited by 19
Bukan, A., Dere, H. B., Jadhav, S., Kasaliwal, R., Budyal, S. R., Shivane, V. K., Lila, A. R., Bandgar, T., & Shah, N. S. (2014) · Endocrine Practice · doi:10.4158/ep14186.or · Cited by 16
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
“29–33 Because urine volume and glom erular filtration rate strongly predict UFC, other screening tests such as LNSC might be preferred for patients with renal impairment (creatinine clearance <60 mL/min) or clinically significant polyuria (>5 L/24 h).”
InfluentialSelf-citationGadelha, M., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 168
Current best practice in the management of patients after pituitary surgery
Prete, A., Corsello, S. M., & Salvatori, R. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816687240 · Cited by 154
The experience with transsphenoidal surgery and its importance to outcomes
Honegger, J. B., & Grimm, F. (2018) · Pituitary · doi:10.1007/s11102-018-0904-4 · Cited by 100
Braun, L., Rubinstein, G., Zopp, S., Vogel, F., Schmid‐Tannwald, C., Escudero, M. P., Honegger, J. B., Ladurner, R., & Reincke, M. (2020) · Endocrine · doi:10.1007/s12020-020-02432-z · Cited by 97
Metadata
- Authors
- Amlashi, F. G., Swearingen, B., Faje, A. T., Nachtigall, L. B., Miller, K. K., Klibanski, A., Biller, B. M. K., & Tritos, N. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tritos, Nicholas A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-10
- Volume
- 100
- Issue
- 10
- Pages
- 3770-3777
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1858878141
- Cited by
- 66
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 6 · 2016: 6
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, late-night salivary cortisol, transsphenoidal surgery, postoperative remission, recurrence detection, 24-hour urine free cortisol, diagnostic accuracy, long-term follow-up
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Circadian Rhythm, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Middle Aged, Postoperative Period, Recurrence, Remission Induction, Retrospective Studies, Saliva, Sensitivity and Specificity, Pituitary ACTH Hypersecretion, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.